ZIMMER BIOMET HOLDINGS, INC. Quarterly Operating Income (Loss) in USD from Q1 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Zimmer Biomet Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2010 to Q3 2024.
  • Zimmer Biomet Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $280M, a 4.84% increase year-over-year.
  • Zimmer Biomet Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $1.25B, a 39.7% increase year-over-year.
  • Zimmer Biomet Holdings, Inc. annual Operating Income (Loss) for 2023 was $1.28B, a 83.5% increase from 2022.
  • Zimmer Biomet Holdings, Inc. annual Operating Income (Loss) for 2022 was $696M, a 19.1% decline from 2021.
  • Zimmer Biomet Holdings, Inc. annual Operating Income (Loss) for 2021 was $860M, a 935% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.25B $280M +$12.9M +4.84% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-30
Q2 2024 $1.24B $351M +$21.7M +6.58% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $1.22B $266M -$61.4M -18.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.28B $354M +$383M Oct 1, 2023 Dec 31, 2023 8-K 2024-08-07
Q3 2023 $895M $267M +$21.3M +8.68% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-30
Q2 2023 $874M $330M +$48.7M +17.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $825M $327M +$129M +65% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $696M -$28.3M -$162M -121% Oct 1, 2022 Dec 31, 2022 8-K 2024-08-07
Q3 2022 $858M $245M +$2.3M +0.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $856M $281M +$56.1M +25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $800M $198M -$60.3M -23.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $860M $134M -$278M -67.5% Oct 1, 2021 Dec 31, 2021 8-K 2024-08-07
Q3 2021 $1.14B $243M -$56.2M -18.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $1.19B $225M +$397M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 $798M $259M +$715M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $83.1M $412M +$100M +32.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$17.2M $299M +$53.4M +21.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$70.6M -$172M -$376M -184% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $306M -$456M -$806M -230% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $1.11B $311M +$1.1B Oct 1, 2019 Dec 31, 2019 8-K 2022-06-22
Q3 2019 $10.2M $246M +$22.5M +10.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$12.3M $205M -$91.3M -30.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $79M $350M +$45.2M +14.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $33.8M -$791M -$750M -1871% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-22
Q3 2018 $784M $223M +$12.1M +5.73% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $772M $296M +$15.9M +5.68% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 $756M $305M -$43.1M -12.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q4 2017 $799M -$40.1M -$219M -122% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-21
Q3 2017 $1.02B $211M +$15.7M +8.03% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $1B $280M +$78.5M +38.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-06
Q1 2017 $924M $348M +$103M +41.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $821M $179M -$35M -16.4% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $856M $196M +$79.5M +68.5% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $777M $202M +$334M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 $443M $246M -$24.4M -9.04% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 $467M $214M -$7.6M -3.44% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $475M $116M -$139M -54.5% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $614M -$132M -$393M -151% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $1.01B $270M -$30.2M -10.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $1.04B $221M -$127M -36.5% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $1.16B $255M +$43.5M +20.5% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.12B $261M +$50.5M +24% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $1.07B $300M +$1.9M +0.64% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 $1.07B $348M +$148M +73.7% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $921M $212M -$37.7M -15.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $959M $210M -$91.5M -30.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 $1.05B $298M +$2.6M +0.88% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-06
Q4 2012 $1.05B $201M -$700K -0.35% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-23
Q3 2012 $1.05B $249M -$17.2M -6.45% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $1.07B $302M +$42.8M +16.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-07
Q1 2012 $1.02B $296M -$1.6M -0.54% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $1.02B $201M +$78.3M +63.7% Oct 1, 2011 Dec 31, 2011 10-K 2014-02-28
Q3 2011 $946M $267M -$5M -1.84% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-06
Q2 2011 $951M $259M +$31M +13.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-07
Q1 2011 $920M $297M +$3.1M +1.05% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q4 2010 $917M $123M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-27
Q3 2010 $272M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q2 2010 $228M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 $294M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.